- Medicina i Cirurgia
Departament
![Foto de - Medicina i Cirurgia](/img/noimage.png)
![Foto de Institute Catalá Oncología](/img/noimage_org.png)
Institute Catalá Oncología
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institute Catalá Oncología (33)
2024
-
Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma
Blood, Vol. 143, Núm. 7, pp. 597-603
2023
-
Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP)
Journal of Pain and Symptom Management, Vol. 66, Núm. 4, pp. 361-369.e6
2022
2021
-
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
Blood, Vol. 137, Núm. 14, pp. 1879-1894
-
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials
Hematological Oncology, Vol. 39, Núm. 4, pp. 529-538
-
Switching Ratio from Parenteral to Oral Methadone 1:1.2 Is Safer Compared with Ratio 1:2 in Patients with Controlled Cancer Pain: A Multicenter Randomized-Controlled Trial (RATIOMTD-010810)
Journal of Palliative Medicine, Vol. 24, Núm. 3, pp. 382-390
2020
-
Proactive and systematic multidimensional needs assessment in patients with advanced cancer approaching palliative care: A study protocol
BMJ Open, Vol. 10, Núm. 2
-
Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice
Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 1, pp. 113-116
-
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265
-
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy
Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. e513-e522
2019
-
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: The ULTRA trial
Annals of Oncology, Vol. 30, Núm. 5, pp. 796-803
-
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma
European Journal of Haematology, Vol. 102, Núm. 5, pp. 389-394
2018
-
Characteristics of the case mix, organisation and delivery in cancer palliative care: A challenge for good-quality research
BMJ Supportive and Palliative Care, Vol. 8, Núm. 4, pp. 456-467
2017
-
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Autophagy, Vol. 13, Núm. 3, pp. 608-624
-
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
European Journal of Cancer, Vol. 75, pp. 73-82
-
Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study
Radiotherapy and Oncology, Vol. 123, Núm. 1, pp. 22-28
2016
-
Competencias y contenidos comunes de salud pública del Grado en Medicina en las universidades españolas
Gaceta Sanitaria, Vol. 30, Núm. 2, pp. 97-103
-
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group
Leukemia Research, Vol. 41, pp. 12-20
-
La Societat Catalano-Balear d’Oncologia: història, present i futur
Annals de Medicina, Vol. 99, Núm. 4, pp. 156-159
2015
-
A decision aid to support informed choices for patients recently diagnosed with prostate cancer
Cancer Nursing, Vol. 38, Núm. 3, pp. E42-E50